The Fungal Infection Trust has been supporting research directly or indirectly through its LIFE program. The many papers published as a result of the FITs support since 2003 are listed below by year.
Publications supported by the Fungal Infection Trust 2024 – 2026
Sengupta A, Ray A, Upadhyay AD, Izumikawa K, Tashiro M, Kimura Y, Bongomin F, Su X, Maitre T, Cadranel J, de Oliveira VF, Iqbal N, Irfan M, Uzunhan Y, Aguilar-Company J, Munteanu O, Beardsley J, Furuuchi K, Takazono T, Ito A, Kosmidis C, Denning DW. Mortality in chronic pulmonary aspergillosis: a systematic review with individual patient meta-analysis. Lancet Infect Dis 2025;25:312-324.
Huseynov RM, Javadli SS, Osmanov A, Kadyrova AA, Askarova SM, Bozdogan B, Oryasin E, Taqiyev BT, Karalti I, Abdulkarimova F, Mammadova M, Hashimova L, Ismayilova N, Mammadova G, Valiyev I, Denning D. TR34/L98H mutation in Aspergillus fumigatus isolate: First report in Azerbaijan. Curr Res Environ Appl Mycol 2025;15: 98–113.
Hatim L, Denning DW. Aspergillus IgG Antibody Testing in the Diagnosis of Hypersensitivity Pneumonitis: A Scoping Review. J Chronic Dis 2025;22:1-12.
Bamber S, Haiduven D, Denning DW. Survey of current national and international guidance to reduce risk of aspergillosis in hospitals. J Hosp Infect 2025;159:124-139.
Kuate MPN, Bongomin F, Denning DW. Chronic Pulmonary Aspergillosis Secondary Infection: A Case Report of Achromobacter spp. Lung Infection. Clin Case Reports 2025; 13:e71121.
Denning DW, Onikan A, Chaves Magri MM, Jiaranaikulwanich A, de Oliveira VF. Radiological features of chronic pulmonary histoplasmosis: Easily mistaken for tuberculosis. PLoS Negl Trop Dis 2025;19(8):e0013219.
Krzyściak PM, Skóra MW, Gniadek A, Denning DW. Estimating the Burden of Serious Mycoses in Poland: A Comprehensive Analysis. Scientific Rep 2025;15:35830.
Plumpton EL, Colombo SAP, Steward M, Brown SL, Khan S, Tavernier G, Francis H, Platt H, Hussell T, Horsnell W, Denning D, Niven R, Simpson A, MacDonald AS, Cook PC. Activation status of airway immune cells is a defining feature of severe asthma, regardless of fungal sensitization. Mucosal Immunol 2026:19:1587-98.
Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis
2024;24:e428-e438.
Bongomin F, Kwizera R, Namusobya M, van Rhijn N, Andia-Biraro I, Kirenga BJ, Meya DB, Denning DW. Re-estimation of the burden of serious fungal diseases in Uganda. Ther Adv Infect Dis 2024;11:20499361241228345.
Rodríguez-Vargas C, Alastruey Izquierdo A, Denning DW, Araúz AB. Estimated burden of fungal infections in Panama. J Med Mycol 2024;34:101466.
Fathallah A, Chouaieb H, Ben Saief M, Ismaïl S, Ben Said M, Denning DW. The incidence and prevalence of serious fungal diseases in Tunisia. J Med Mycol 2024;34:101479.
Lewis R, Niazi-Ali S, McIvor A, Sharah SK, Maertens J, Bassetti M, Levine D, Groll A, Denning DW. Triazole antifungal drug interactions – practical considerations for excellent prescribing. J Antimicrob Chemother 2024;79:1203-1217.
Al Dhaheri F, Thomsen J, Everett D, Denning DW. Mapping the burden of fungal diseases in the United Arab Emirates. J Fungi 2024;10:353.
Denning DW, Herbrecht R. Terbinafine for disseminated fusarosis and invasive aspergillosis – a poor partner for amphotericin B (Comment). Open Forum Infect Dis 2024
Mohammad KA, Ismail HM, Shekhany KAM, Yashooa RK, Younus DA, Abdullah SK, Alatraqchi AAF, Aldabbagh R, Denning DW. Fungal disease incidence and prevalence in Iraq – Preliminary estimates. J Mycol Med 2024;34:101516.